Research suggests that certain weight-loss drugs, including GLP-1 agonists such as Ozempic and Wegovy, may have additional benefits beyond weight loss, potentially slowing biological aging. These drugs may also have positive effects for people with conditions like HIV and cancer. The accessibility and affordability of these medications are being considered, as their potential benefits are being explored.